This panel, first recorded at the 2022 IO360° Summit, reported on advances in achieving more diversity and inclusion in oncology clinical trials.

Moderated by:
Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical Trial Operations, Merck Research Labs

Panelists:

Chétna Rao, PhD, Head of Site Strategy and Operations, BMS
Robert Vonderheide, MD, DPhil, Director, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Karen Peterson, Patient Advocate and Founder, Karen’s Club
Michel Reid, Sr. Director and Head, Global Demographics & Diversity, Global Clinical, Delivery, Global Clinical Operations, R&D, GSK

Learn more about the IO360° Summit at www.io360summit.com